Time-to-Rebound Measurements in ATI Trials With bNAb Intervention Are Confounded by Autologous NAbs

10-1074 - National Institute of Allergy and Infectious Diseases, Rockefeller University, Gilead

3BNC117 - Rockefeller University, Cornell University, Frontier Biotech, Gilead

Intron A (interferon α-2b) - Merck (MSD), Biogen

https://www.croiconference.org/abstract/1267-2025/

Mauro Garcia; Junlin Zhuo; Emmanouil Papasavvas; Brianna Lopez; Anthony Abeyta-Lopez; Beril Aydin; Joseph Varriale; Jun Lai; Livio Azzoni; Kenneth Lynn; Karam Mounzer; Pablo Tebas; Luis J. Montaner; Robert F. Siliciano; Janet M. Siliciano

Mar 4, 2025